| 2025 | | Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study
Diabetes & metabolism, 51(5). : 101668-101668, 2025 | 김대중, 하경화, 한승진 |
| 2025 | | Effectiveness of gemigliptin on risk of major adverse kidney events in people with type 2 diabetes: A Korean cohort study
Diabetes, obesity & metabolism, 27(4). : 2313-2316, 2025 | 김대중, 하경화 |
| 2025 | | Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study
Journal of diabetes and its complications, 39(5). : 108983-108983, 2025 | 김대중, 하경화 |
| 2025 | | Trends in prescribing sodium-glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular-renal disease in South Korea, 2015–2021
Journal of diabetes investigation, 16(2). : 215-224, 2025 | 김대중, 하경화 |
| 2024 | | Combined impact of prediabetes and hepatic steatosis on cardiometabolic outcomes in young adults
Cardiovascular diabetology, 23(1). : 422-422, 2024 | 김대중, 하경화 |
| 2024 | | Changes in the Epidemiological Landscape of Diabetes in South Korea: Trends in Prevalence, Incidence, and Healthcare Expenditures
Endocrinology and metabolism (Seoul, Korea), 39(5). : 669-677, 2024 | 김대중, 하경화 |
| 2024 | | Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium
The lancet. Diabetes & endocrinology, 12(12). : 915-923, 2024 | 김대중, 하경화 |
| 2024 | | Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease
Endocrinology and metabolism (Seoul, Korea), 39(4). : 622-631, 2024 | 김대중, 하경화 |
| 2024 | | Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study
Korean circulation journal, 54(5). : 256-267, 2024 | 김대중, 하경화 |
| 2024 | | Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations
Journal of diabetes investigation, 15(3). : 285-287, 2024 | 김대중, 하경화 |
| 2023 | | Impact of prolonged carbapenem use-focused antimicrobial stewardship on antimicrobial consumption and factors affecting acceptance of recommendations: a quasi-experimental study
Scientific reports, 13(1). : 14501-14501, 2023 | 김영롱, 김은진, 유진세, 최영화, 하경화, 허중연 |
| 2023 | | Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
Cardiovascular diabetology, 22(1). : 233-233, 2023 | 김대중, 하경화 |
| 2023 | | Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea
Diabetes care, 46(9). : 1700-1706, 2023 | 김대중, 하경화 |
| 2023 | | Diet quality partially mediates the association between ultraprocessed food consumption and adiposity indicators
Obesity (Silver Spring, Md.), 31(9). : 2430-2439, 2023 | 김대중, 하경화 |
| 2023 | | Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide population-based cohort study
Diabetes research and clinical practice, 203. : 110820-110820, 2023 | 김대중, 하경화, 한승진 |
| 2023 | | Ultra-Processed Food Consumption and Obesity in Korean Adults
Diabetes & metabolism journal, 47(4). : 547-558, 2023 | 김대중, 하경화 |
| 2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes & metabolism, 49(2). : 101418-101418, 2023 | 김대중, 하경화 |
| 2023 | | Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes
The Korean journal of internal medicine, 38(1). : 93-100, 2023 | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study
Journal of diabetes investigation, 14(3). : 417-428, 2023 | 김대중, 하경화 |
| 2022 | | Association of prediabetes with death and diabetic complications in older adults: The pros and cons of active screening for prediabetes
Age and ageing, 51(6). : afac116-afac116, 2022 | 김대중, 하경화 |
| 2022 | | Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes
Journal of obesity & metabolic syndrome, 31(2). : 187-195, 2022 | 김대중, 하경화 |
| 2022 | | Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study
Diabetes & metabolism journal, 46(5). : 803-807, 2022 | 김대중, 하경화 |
| 2022 | | Association between Metabolically Healthy Obesity and Subclinical Atherosclerosis in the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort
Journal of clinical medicine, 11(9). : 2440-2440, 2022 | 김대중, 하경화 |
| 2022 | | Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
The lancet. Diabetes & endocrinology, 10(11). : 795-803, 2022 | 김대중, 하경화 |
| 2022 | | Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
The lancet. Diabetes & endocrinology, 10(2). : 112-119, 2022 | 김대중, 하경화 |
| 2022 | | Temporal Association of Total Serum Cholesterol and Pancreatic Cancer Incidence
Nutrients, 14(22). : 4938-4938, 2022 | 하경화 |
| 2022 | | Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study
International journal of environmental research and public health, 19(5). : 2823-2823, 2022 | 김대중, 김은진, 정윤정, 최영화, 하경화, 허중연 |
| 2022 | | Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study
Journal of diabetes investigation, 13(6). : 986-996, 2022 | 김대중, 최용준, 하경화 |
| 2022 | | Healthcare resource utilization in patients treated with empagliflozin in East Asia
Journal of diabetes investigation, 13(5). : 810-821, 2022 | 김대중, 하경화 |
| 2021 | | Erratum: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea
Diabetes & metabolism journal, 45(2). : 283-283, 2021 | 김대중, 하경화 |
| 2021 | | Air pollution and risk of hospital outpatient visits for eczematous skin disorders in metropolitan cities of South Korea
The British journal of dermatology, 185(3). : 641-644, 2021 | 하경화 |
| 2021 | | Effect of teneligliptin versus sulfonylurea on major adverse cardiovascular outcomes in people with type 2 diabetes mellitus: A real-world study in Korea
Endocrinology and metabolism (Seoul, Korea), 36(1). : 70-80, 2021 | 김대중, 하경화 |
| 2021 | | Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings
The lancet. Diabetes & endocrinology, 9(4). : 203-211, 2021 | 김대중, 하경화 |
| 2021 | | Trends in cardiovascular complications and mortality among patients with diabetes in South Korea
Diabetes & metabolism journal, 45(1). : 120-124, 2021 | 김대중, 하경화 |
| 2021 | | Cardiovascular safety of sodium glucose cotransporter 2 inhibitors as add-on to metformin monotherapy in patients with type 2 diabetes mellitus
Diabetes & metabolism journal, 45(4). : 505-514, 2021 | 김대중, 전자영, 하경화 |
| 2021 | | Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study
Diabetes, obesity & metabolism, 23(3). : 682-691, 2021 | 김대중, 이나미, 하경화, 한승진 |
| 2021 | | Trends in the effects of pre-transplant diabetes on mortality and cardiovascular events after kidney transplantation
Journal of diabetes investigation, 12(5). : 811-818, 2021 | 박범희, 오창권, 전자영, 하경화, 한승진 |
| 2021 | | Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
Diabetes, obesity & metabolism, 23(1). : 75-85, 2021 | 김대중, 하경화 |
| 2020 | | Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
Endocrinology, diabetes & metabolism, 4(1). : e00183-e00183, 2020 | 김대중, 하경화 |
| 2020 | | Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database
Cancer research and treatment, 52(4). : 1262-1272, 2020 | 하경화 |
| 2020 | | Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea
Diabetes & metabolism journal, 44(6). : 933-937, 2020 | 김대중, 박인휘, 이민정, 하경화 |
| 2020 | | Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study
Cardiovascular diabetology, 19(1). : 191-191, 2020 | 김대중, 하경화 |
| 2020 | | Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis
Diabetes & metabolism journal, 44(6). : 928-932, 2020 | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640-8)
Diabetes & metabolism journal, 43(6). : 917-918, 2019 | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Diabetes and the Risk of Infection: A National Cohort Study
Diabetes & metabolism journal, 43(6). : 804-814, 2019 | 김대중, 김은진, 최영화, 하경화 |
| 2019 | | Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status
Diabetes & metabolism journal, 43(4). : 487-494, 2019 | 김대중, 하경화 |
| 2019 | | Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study
PloS one, 14(10). : e0224549-e0224549, 2019 | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Cohort Profile: The Cardiovascular and Metabolic Diseases Etiology Research Center Cohort in Korea
Yonsei medical journal, 60(8). : 804-810, 2019 | 김대중, 하경화 |
| 2019 | | Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study
PloS one, 14(2). : e0211959-e0211959, 2019 | 김대중, 하경화 |
| 2019 | | The Association of Adiponectin and Visceral Fat with Insulin Resistance and beta-Cell Dysfunction
Journal of Korean medical science, 34(1). : e7-e7, 2019 | 김대중, 김혜진, 문현욱, 하경화, 한승진 |
